GE HealthCare Technologies Inc. $GEHC Shares Acquired by Praxis Investment Management Inc.

Praxis Investment Management Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 86.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 18,516 shares of the company’s stock after acquiring an additional 8,606 shares during the quarter. Praxis Investment Management Inc.’s holdings in GE HealthCare Technologies were worth $1,391,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of the business. Glenview Trust co lifted its holdings in GE HealthCare Technologies by 4.4% in the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock worth $266,000 after purchasing an additional 139 shares during the period. Silver Oak Securities Incorporated raised its position in shares of GE HealthCare Technologies by 4.6% during the 2nd quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock worth $236,000 after buying an additional 140 shares in the last quarter. Chicago Capital LLC raised its position in shares of GE HealthCare Technologies by 2.2% during the 2nd quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock worth $485,000 after buying an additional 141 shares in the last quarter. Fort Washington Investment Advisors Inc. OH lifted its stake in shares of GE HealthCare Technologies by 4.2% in the 2nd quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock worth $263,000 after acquiring an additional 143 shares during the period. Finally, Golden State Wealth Management LLC boosted its holdings in shares of GE HealthCare Technologies by 7.4% in the second quarter. Golden State Wealth Management LLC now owns 2,138 shares of the company’s stock valued at $158,000 after acquiring an additional 148 shares in the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ GEHC opened at $83.96 on Monday. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a market cap of $38.25 billion, a PE ratio of 17.35, a PEG ratio of 3.51 and a beta of 1.09. The stock’s 50-day moving average price is $76.82 and its two-hundred day moving average price is $75.02.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, topping the consensus estimate of $1.05 by $0.02. GE HealthCare Technologies had a net margin of 10.94% and a return on equity of 22.52%. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. During the same period last year, the firm posted $1.14 earnings per share. The firm’s quarterly revenue was up 5.8% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Shareholders of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s payout ratio is 2.89%.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Evercore ISI increased their price target on GE HealthCare Technologies from $88.00 to $92.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Barclays initiated coverage on GE HealthCare Technologies in a report on Monday, October 13th. They set an “equal weight” rating and a $86.00 target price on the stock. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a report on Monday, September 29th. Finally, Jefferies Financial Group increased their target price on shares of GE HealthCare Technologies from $95.00 to $105.00 and gave the company a “buy” rating in a research note on Thursday. Six analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $87.09.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.